Abstract: New findings from the UK Biobank are reshaping how we think about early Parkinson’s detection, using something as simple as daily steps. In a large prospective study, researchers analyzed accelerometer-measured step counts from nearly 95,000 adults to understand whether declining activity can signal Parkinson’s disease years before diagnosis. Powered by UK Biobank’s deeply phenotyped dataset and high-quality wearable data, the study reveals that people who eventually develop Parkinson’s often show a steady drop in daily steps long before clinical symptoms appear. What makes this compelling is the precision of device-measured steps, offering insights free from recall bias and providing a scalable, real-world digital biomarker.
But there’s a twist, higher step counts were strongly linked with lower Parkinson’s incidence only in the short follow-up windows, the first two to four years. Beyond six years, the association faded, suggesting that fewer steps are not a “risk factor,” but an early sign of the disease silently unfolding. This is where biobanking becomes pivotal. With UK Biobank’s integration of accelerometry, clinical records, and longitudinal follow-up, researchers can distinguish true causal relationships from early disease signals. Such datasets enable global teams to validate digital markers, refine prodromal risk profiles, and eventually pair step trends with imaging, genetics, or biospecimens for precision detection frameworks.
Read this entire article here: https://www.news-medical.net/news/20251125/Daily-walking-patterns-help-flag-early-Parkinsone28099s-signs-in-large-UK-study.aspx
